Lipella Pharmaceuticals Faces Mixed Signals Amid Volatility Lipella Pharmaceuticals Inc. stock has experienced significant fluctuations, losing 0.385% on March 21, 2025, closing at $2.59. Analysts forecast a potential 13.93% decline over three months, though short-term buy signals persist. The stock remains high-risk due to its low trading volume and market volatility.12